Breaking Barriers In ED Treatment: A 100% Recruitment Success!

In their meaningful collaboration, palleos healthcare, a leading European CRO, teamed up with a UK-based biotech to conduct a study to evaluate the innovative topical gel for the treatment of erectile dysfunction (ED).

The confirmatory trial successfully enrolled 100 male participants with diverse demographics across four countries – Poland, Georgia, the USA, and Bulgaria. Efficiently completed and ahead of schedule, the study marks a significant advancement in ED treatment options. It showcases how a CRO’s expertise in managing complex, multi-national clinical trials can contribute to the success of a study.

Download the full text to learn more about this study’s outcomes.